Top news of the week: 26.05.2020.
Antibody, Vaccination, Virus, Vaccine, Pharmaceutical drug, Bill & Melinda Gates Foundation
Startups
RT @pfizer: “Make the impossible possible.” Go behind the scenes of the unprecedented race to develop a vaccine to fight #COVID19 in this article from @Forbes. https://t.co/eJQEnWD9hK
OpenThe inside story behind the pandemic, the CEO and a promising, unproven treatment.
The inside story behind the pandemic, the CEO and a promising, unproven treatment.
News of the closure of Cowen’s third fund continues a series of announcements investors have put out against the backdrop of the COVID-19 pandemic. https://t.co/gw7qGOo9Rv
OpenCowen raises $493M fund, further expanding biotech VC pot
Cowen Healthcare Investments has raised a $493 million fund, breezing past its original goal by close to $100 million. The fund closure positions Cowen to continue following an investment ...
Moderna taps $1.34B stock offering to bankroll its promising COVID-19 vaccine https://t.co/OlydyRFDwI
OpenHonoring the leaders in pharma marketing and advertising. Applications are due June 15th.
Money from the largest biotech IPO in history, funding from an international outbreak preparedness group and an award from the U.S. government are apparently still not enough for Moderna. ...
RT @drsam: So happy to be able to share the news of what we've been working on for the past 18 months.
We're very please to announce Day One Biopharmaceuticals (@DayOneBio), our Series A, our incredible team, and our lead program.
https://t.co/1sXLwDD6oX
OpenStartup Spotlight: Aiming to speed precision cancer therapies to children
A San Francisco startup is targeting low-grade gliomas, planning to make precision treatments as available for kids with cancer as they are for adults.
"We are very excited to have found this potent neutralizing antibody that we hope will participate in ending the COVID-19 pandemic."
$VIR
https://t.co/sW6vFNpc97
OpenPromising COVID-19 Antibodies Examined Using Cryo-EM and X-ray Crystallography
Scientists reveal potential COVID-19 therapy using structural biology to further understand SARS-CoV-2 neutralizing antibodies.
Biopharma Update on the Novel Coronavirus: May 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
Meet some of the #COVIDbusters! @JFruehauf chatted with senior execs from four @LabCentral companies who shifted their work to address the COVID-19 crisis. Hear some of the innovative ways they are responding to the pandemic: https://t.co/SQGjPexEXT @CrossTalk
OpenMeet the COVID busters: Biotech startups pivoting to address the pandemic
Johannes Fruehauf, co-founder of LabCentral, interviews four biotech startup executives about their coronavirus response.
A Silicon Valley exodus, law firm drama, and the most consequential startup of all time https://t.co/VqooxF58Dq
OpenA Silicon Valley exodus, law firm drama, and the most consequential startup of all time
The remote work movement is accelerating, with Facebook, Twitter, Square, and Shopify signaling a permanent shift. What does that mean for Silicon Valley?